Key Highlights
- Natural Health Trends (NASDAQ:NHTC) showed an indicated Yield of 48.19% at USD 0.83 on the high-dividend screen on November 6, 2026, down 6.64%, with a Market Value of about USD 7.05 million.
- Third-quarter 2026 Revenue fell 20% to USD 7.6 million and the net loss narrowed to USD 232,000, or USD 0.03 per share, in results released on October 28.
- Dividends paid in the first nine months of 2026 totalled USD 1.7 million, down from USD 6.9 million a year earlier, and the latest release did not declare a new dividend.
- Cash and marketable securities were USD 17.6 million and stockholders' Equity was USD 15.0 million at September 30, 2026, both well above the market value.
Why the Yield Looks So High
The 48.19% figure for Natural Health Trends (NASDAQ:NHTC) comes from dividends paid over the past year measured against a share price that has fallen below USD 1. The payout itself has been shrinking. Dividends paid in the first nine months of 2026 were USD 1.7 million against USD 6.9 million in the same period of 2025, a cut of about 75%. The third-quarter release, issued on October 28, 2026, did not include a new Dividend declaration. That means the indicated yield is largely a function of the price decline rather than a stable income stream. A falling price lifts any trailing yield, but it also signals that investors doubt the payout will continue at past levels. On the available evidence, the yield looks distorted by the price drop and is not supported by a current declaration.
Business Trends and Balance Sheet
The direct-selling company, which earns most of its sales in China through its Hong Kong operation, reported third-quarter revenue of USD 7.6 million, down 20% from USD 9.5 million a year earlier and flat against the second quarter. Cost reductions narrowed the net loss to USD 232,000 from USD 451,000 in the second quarter. Revenue for the first nine months fell 19% to USD 24.4 million, with a net loss of USD 837,000. The Balance Sheet remains the main support. Cash and marketable securities of USD 17.6 million, down from USD 28.9 million at the end of 2025, compare with a market value of about USD 7 million. The company also bought back 57,269 shares in October and has about USD 15.8 million left under its repurchase authorisation. Stockholders' equity of USD 15.0 million implies a Book Value of roughly USD 1.75 per share, about twice the screen price, which shows how far sentiment has fallen even with net losses kept small.
Risks and What to Watch
Shrinking sales in China remain the core risk, as regulation and consumer Demand continue to weigh on direct selling. Cash has fallen by about USD 11 million this year, partly due to dividends, so the balance sheet cannot fund large payouts indefinitely without a return to profit. A share price below USD 1 also raises the risk of Nasdaq minimum bid compliance issues, although no notice has been confirmed. The 6.64% fall on November 6 had no confirmed trigger, as no announcement dated November 4 to 6 was found. Investors should watch any dividend decision, cash levels and sales trends in the fourth quarter.
Where Things Stand
Natural Health Trends screens at a 48.19% yield because past dividends are being measured against a price of USD 0.83. Dividend payments are down about 75% this year, no new declaration was made with third-quarter results, and revenue fell 20%. Cash of USD 17.6 million exceeds the market value, which keeps the company's balance sheet in focus. The next board decision on payouts will show whether any yield remains.






Please wait processing your request...